Actinogen down 38% after yesterday's ASX debut

The share price of Perth-based biotech firm Actinogen Ltd has fallen again in the company's second day of trade on the Australian Securities Exchange, closing today at 31 cents, down 19 cents from its offer price.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer